fianlimab,cemiplimab
sanofi,regeneron
['melsm', 'fianlimab', 'cemiplimab', 'melanoma']
. s dr. eugenia girda &amp; colleagues present significant durable response with fianlimab (anti-lag-3) &amp; cemiplimab (anti-pd-1) in advanced #melanoma: post adjuvant pd-1 analysis. #asco23 #melsm 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.